These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8695922

  • 61. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE, Cadena RS, Raimondi SC, Beck WT.
    Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
    [Abstract] [Full Text] [Related]

  • 62. Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells.
    Pan X, Hartley JM, Hartley JA, White KN, Wang Z, Bligh SW.
    Phytomedicine; 2012 May 15; 19(7):618-24. PubMed ID: 22402246
    [Abstract] [Full Text] [Related]

  • 63. DNA topoisomerase inhibitors as antifungal agents.
    Shen LL, Fostel JM.
    Adv Pharmacol; 1994 May 15; 29B():227-44. PubMed ID: 8996610
    [No Abstract] [Full Text] [Related]

  • 64. Induction of apoptosis in malignant and camptothecin-resistant human cells.
    Chatterjee D, Wyche JH, Pantazis P.
    Ann N Y Acad Sci; 1996 Dec 13; 803():143-56. PubMed ID: 8993507
    [Abstract] [Full Text] [Related]

  • 65. Dual inhibition of topoisomerases enhances apoptosis in melanoma cells.
    Rudolf K, Cervinka M, Rudolf E.
    Neoplasma; 2010 Dec 13; 57(4):316-24. PubMed ID: 20429622
    [Abstract] [Full Text] [Related]

  • 66. Involvement of DNA topoisomerases and DNA topoisomerase inhibitors in the induction of leukemia cell differentiation.
    Larsen AK.
    Ann Oncol; 1994 Oct 13; 5(8):679-88. PubMed ID: 7826899
    [No Abstract] [Full Text] [Related]

  • 67. Transient activation of topoisomerase I in leukotriene D4 signal transduction in human cells.
    Mattern MR, Mong S, Mong SM, Bartus JO, Sarau HM, Clark MA, Foley JJ, Crooke ST.
    Biochem J; 1990 Jan 01; 265(1):101-7. PubMed ID: 2154178
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Topoisomerase inhibitors potentiate the effect of retinoic acid on cell growth inhibition and induction of differentiation of leukemia HL-60 cells.
    Jing Y, Hashimoto S, Nakajo S, Nakaya K.
    Leuk Res; 1994 Apr 01; 18(4):299-304. PubMed ID: 8170172
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines.
    Couldwell WT, Hinton DR, He S, Chen TC, Sebat I, Weiss MH, Law RE.
    FEBS Lett; 1994 May 23; 345(1):43-6. PubMed ID: 8194597
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Apoptotic pathways depend on the target enzymatic activity and not on the triggering agent.
    Luchetti F, Mariani AR, Columbaro M, Di Baldassarre A, Cinti C, Falcieri E.
    Scanning; 1999 May 23; 21(1):29-35. PubMed ID: 10070781
    [Abstract] [Full Text] [Related]

  • 75. Modulation of drug-induced apoptosis in a human B-lymphoma cell line (HT58).
    Mihalik R, Kopper L, Benczúr M.
    Immunol Lett; 1995 Nov 23; 48(1):17-21. PubMed ID: 8847085
    [Abstract] [Full Text] [Related]

  • 76. Differentiated and exponentially growing HL60 cells exhibit different sensitivity to some genotoxic agents in the comet assay.
    Montag G, Bankoglu EE, Bolte A, Hintzsche H, Djelic N, Stopper H.
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Sep 23; 845():402972. PubMed ID: 31561892
    [Abstract] [Full Text] [Related]

  • 77. Topoisomerases in human leukemia.
    Peereboom D, Charron M, Kaufmann SH.
    Adv Pharmacol; 1994 Sep 23; 29B():33-50. PubMed ID: 8996600
    [No Abstract] [Full Text] [Related]

  • 78. Rapid evaluation of topoisomerase inhibitors: caffeine inhibition of topoisomerases in vivo.
    Shin CG, Strayer JM, Wani MA, Snapka RM.
    Teratog Carcinog Mutagen; 1990 Sep 23; 10(1):41-52. PubMed ID: 1971968
    [Abstract] [Full Text] [Related]

  • 79. Studies of the differentiation properties of camptothecin in the human leukaemic cells K562.
    McSheehy PM, Gervasoni M, Lampasona V, Erba E, D'Incalci M.
    Eur J Cancer; 1991 Sep 23; 27(11):1406-11. PubMed ID: 1660292
    [Abstract] [Full Text] [Related]

  • 80. Effect of extracellular magnesium on topoisomerase II activity and expression in human leukemia HL-60 cells.
    Covacci V, Bruzzese N, Sgambato A, Ganapathi R, Cittadini A, Wolf FI.
    J Cell Biochem; 2000 May 23; 78(2):325-33. PubMed ID: 10842326
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.